Your browser doesn't support javascript.
loading
Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block?
Eibl, Guido; Buhr, Heinz J; Foitzik, Thomas.
Afiliação
  • Eibl G; Department of Surgery, Benjamin Franklin Medical Center, Freie Universität Berlin, Germany. Geibl@mednet.ucla.edu
Intensive Care Med ; 28(2): 139-46, 2002 Feb.
Article em En | MEDLINE | ID: mdl-11907656
ABSTRACT

OBJECTIVE:

To compare the effect of different vasoactive mediator antagonists in the same model of severe acute pancreatitis (AP) and to evaluate whether combinations of the agents exhibit synergistic effects.

DESIGN:

Prospective experimental study.

SETTING:

Microcirculation and pancreas research laboratory at an university hospital.

PARTICIPANTS:

Hundred eighty anesthetized male Sprague-Dawley rats.

INTERVENTIONS:

Six hours after inducing AP by intra-ductal bile salt infusion and i.v. cerulein in 168 rats, these were randomized for therapy with (1) saline, (2) endothelin receptor antagonist (ET-RA), (3) platelet activating factor receptor antagonist (PAF-RA), (4) intercellular adhesion molecule-1 antibody (ICAM-1-AB) or different combinations (5-7). After 24 h the animals underwent a second laparotomy for intra-vital microscopic determination of pancreatic and colonic capillary permeability, blood flow and leukocyte-endothelial interaction.

RESULTS:

AP induction decreased capillary blood flow and increased permeability and leukocyte rolling. ET-RA, PAF-RA and ICAM-1-AB decreased capillary permeability, increased blood flow and reduced leukocyte rolling. ET-RA was most effective in decreasing capillary permeability in both organs as well as in increasing pancreatic capillary blood flow. Combining vasoactive mediator blockers did not further improve target parameters.

CONCLUSIONS:

This study supports previous observations that ET-RA, PAF-RA and ICAM-1-AB improve microcirculation in AP and that ET-RA is more effective than PAF-RA or ICAM-1-AB, especially in counteracting capillary leakage. Although this may suggest that they act through different mechanisms, antagonist combinations failed to improve microcirculation further. We conclude that ET-RA is the most promising candidate for a clinical trial to reduce capillary leakage in patients with AP.
Assuntos
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pancreatite / Doenças Vasculares / Glicoproteínas da Membrana de Plaquetas / Receptores de Superfície Celular / Molécula 1 de Adesão Intercelular / Receptores Acoplados a Proteínas G / Antagonistas dos Receptores de Endotelina / Microcirculação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Buscar no Google
Base de dados: MEDLINE Assunto principal: Pancreatite / Doenças Vasculares / Glicoproteínas da Membrana de Plaquetas / Receptores de Superfície Celular / Molécula 1 de Adesão Intercelular / Receptores Acoplados a Proteínas G / Antagonistas dos Receptores de Endotelina / Microcirculação Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Ano de publicação: 2002 Tipo de documento: Article